October 25, 2018
Rose
If the Chinese company's technology can do what executives say it can, then the competition it brings into the marketplace could drive down the already-plummeting cost of genome sequencing. Other industry news focuses on hospices, health care systems, and hospitals.
from Kaiser Health News https://ift.tt/2EKf4zB
October 25, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: Spike Of Paralysis Cases In Minn. Children; Potential Beth Israel-Lahey Merger Faces New Conditions From Mass. Officials- More Floridians Could Be Exposed To Toxic Red Tide As Hurricane Michael Pushes It Ashore
- When Doctors Are Stumped By Rare Cases, They Can Call In These ‘Disease Detectives’
- Former Pa. Gov. Ed Rendell Throws Gauntlet Over Philadelphia Safe Injection Site: ‘Come And Arrest Me’
- Roundup-Maker May Get New Trial That Could Undermine $250M In Punitive Damages Awarded To Groundskeeper
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment